Consonance Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Consonance Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-388,222	Closed	-$14.2M	–	30
2021 Q2	$14.2M	Sell	388,222 -605,690	-61%	-$23.5M	1.71%	14
2021 Q1	$44.6M	Buy	993,912 +509,241	+105%	+$23.7M	4.75%	7
2020 Q4	$27.7M	Buy	+484,671	New	+$28.7M	2.58%	15

Other funds holding DCPH

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Consonance Capital Management's DCPH Position: Q3 2021 in Review

Consonance Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2021, closing a stake of 388,222 shares — an estimated $14.2M sold.

Consonance Capital Management first reported a position in DCPH in Q4 2020 and held it in 3 quarters. The position peaked at $44.6M in Q1 2021. 161 funds tracked by Wall St. Rank hold DCPH as of Q3 2021.

Consonance Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Consonance Capital Management sold 388,222 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $14.2M.
Consonance Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
Consonance Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $44.6M in Q1 2021.
161 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Consonance Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.